| WKN: | 603035 |
| ISIN: | US0042251084 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Acadia Pharmaceuticals-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 09. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2013 | 3,36 | 18,04 | 436,90% |
| 2 | 2012 | 0,85 | 3,36 | 295,29% |
| 3 | 2019 | 13,73 | 38,82 | 182,74% |
| 4 | 2023 | 14,83 | 28,00 | 88,81% |
| 5 | 2005 | 4,38 | 8,25 | 88,36% |
| 6 | 2009 | 0,56 | 0,90 | 60,71% |
| 7 | 2014 | 18,04 | 25,81 | 43,07% |
| 8 | 2015 | 25,81 | 32,32 | 25,22% |
| 9 | 2025 | 16,10 | 19,88 | 23,48% |
| 10 | 2007 | 6,75 | 7,57 | 12,15% |
| 11 | 2020 | 38,82 | 43,31 | 11,57% |
| 12 | 2011 | 0,82 | 0,85 | 3,66% |
| 13 | 2026 | 19,88 | 19,18 | -3,52% |
| 14 | 2017 | 26,85 | 25,57 | -4,77% |
| 15 | 2010 | 0,90 | 0,82 | -8,89% |
| 16 | 2016 | 32,32 | 26,85 | -16,92% |
| 17 | 2006 | 8,25 | 6,75 | -18,18% |
| 18 | 2022 | 21,01 | 14,83 | -29,41% |
| 19 | 2024 | 28,00 | 16,10 | -42,50% |
| 20 | 2018 | 25,57 | 13,73 | -46,30% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2008 | 7,57 | 0,56 | -92,60% |
| 2 | 2021 | 43,31 | 21,01 | -51,49% |
| 3 | 2018 | 25,57 | 13,73 | -46,30% |
| 4 | 2024 | 28,00 | 16,10 | -42,50% |
| 5 | 2022 | 21,01 | 14,83 | -29,41% |
| 6 | 2006 | 8,25 | 6,75 | -18,18% |
| 7 | 2016 | 32,32 | 26,85 | -16,92% |
| 8 | 2010 | 0,90 | 0,82 | -8,89% |
| 9 | 2017 | 26,85 | 25,57 | -4,77% |
| 10 | 2026 | 19,88 | 19,18 | -3,52% |
| 11 | 2011 | 0,82 | 0,85 | 3,66% |
| 12 | 2020 | 38,82 | 43,31 | 11,57% |
| 13 | 2007 | 6,75 | 7,57 | 12,15% |
| 14 | 2025 | 16,10 | 19,88 | 23,48% |
| 15 | 2015 | 25,81 | 32,32 | 25,22% |
| 16 | 2014 | 18,04 | 25,81 | 43,07% |
| 17 | 2009 | 0,56 | 0,90 | 60,71% |
| 18 | 2005 | 4,38 | 8,25 | 88,36% |
| 19 | 2023 | 14,83 | 28,00 | 88,81% |
| 20 | 2019 | 13,73 | 38,82 | 182,74% |